LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 405.00 shares, a 97.36% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 11.14K shares, a 15.14% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 46.77K shares, a 45.48% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 58.32K shares, a 50.20% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 117.11K shares, a 70.68% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 399.37K shares.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 136.08K shares, a 209.19% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 2 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 10 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-07 | |||||||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 405.00 shares derived: sum of 2 quarters · filed 2026-02-27 | 11.55K shares derived: sum of 3 quarters · filed 2026-02-27 | 58.32K shares 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | 405.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 11.55K shares derived: sum of 2 quarters · filed 2025-11-07 | 58.32K shares 10-Q · filed 2025-11-07 | 118.27K shares derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2025-06-30 | 11.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 57.91K shares 10-Q · filed 2025-08-08 | 117.87K shares derived: sum of 3 quarters · filed 2026-02-27 | 133.20K shares derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2025-03-31 | 46.77K shares 10-Q · filed 2025-05-09 | 106.72K shares derived: sum of 2 quarters · filed 2026-02-27 | 122.06K shares derived: sum of 3 quarters · filed 2026-02-27 | 131.74K shares derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-12-31 | 59.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 75.29K shares derived: sum of 2 quarters · filed 2026-02-27 | 84.96K shares derived: sum of 3 quarters · filed 2026-02-27 | 117.11K shares 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | 15.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 25.01K shares derived: sum of 2 quarters · filed 2024-11-08 | 57.16K shares 10-Q · filed 2024-11-08 | 117.79K shares derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | 9.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 41.83K shares 10-Q · filed 2024-08-07 | 102.46K shares derived: sum of 3 quarters · filed 2026-02-27 | |||||
| 2024-03-31 | 32.15K shares 10-Q · filed 2024-05-08 | 92.78K shares derived: sum of 2 quarters · filed 2026-02-27 | ||||||
| 2023-12-31 | 60.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 399.37K shares 10-K · filed 2026-02-27 | ||||||
| 2023-09-30 | 338.74K shares 10-Q · filed 2023-11-09 | |||||||
| 2022-12-31 | 542.84K shares 10-K · filed 2025-02-28 | |||||||
| 2022-11-01 | 2.99M shares 10-K · filed 2025-02-28 | |||||||
| 2022-10-31 | 40.07K shares 10-K · filed 2025-02-28 | |||||||
| 2021-12-31 | 136.08K shares 10-K · filed 2024-02-29 | |||||||
| 2020-12-31 | 44.01K shares 10-K · filed 2023-02-28 | |||||||
| 2019-12-31 | 6.53K shares 10-K · filed 2022-02-28 | |||||||
| 2018-12-31 | 10.23K shares 10-K · filed 2021-02-24 | |||||||
| 2018-06-30 | 12.23K shares 10-Q · filed 2018-08-08 | |||||||
| 2017-12-31 | 3.04K shares 10-K · filed 2018-03-01 | |||||||
| 2016-12-31 | 28.11K shares 10-K · filed 2017-02-28 | |||||||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2016-11-14 | 78.69K shares 10-K · filed 2016-11-14 | |||||
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 78.69K shares 10-Q · filed 2015-11-09 | ||||||
| 2015-06-30 | 78.69K shares 10-Q · filed 2015-08-05 | |||||||
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | 0.00 shares derived: sum of 2 quarters · filed 2015-02-23 | 6.48K shares derived: sum of 3 quarters · filed 2015-02-23 | 49.97K shares 10-K · filed 2015-02-23 | 73.98K shares 10-K · filed 2014-12-01 | |||
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | 6.48K shares derived: sum of 2 quarters · filed 2014-10-31 | 49.97K shares 10-Q · filed 2014-10-31 | 49.97K shares derived: sum of 4 quarters · filed 2014-12-12 | ||||
| 2014-06-30 | 6.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | 49.97K shares 10-Q · filed 2014-08-05 | 49.97K shares derived: sum of 3 quarters · filed 2014-12-12 | 73.82K shares derived: sum of 4 quarters · filed 2014-12-12 | ||||
| 2014-03-31 | 43.49K shares 10-Q · filed 2014-05-07 | 43.49K shares derived: sum of 2 quarters · filed 2014-12-12 | 67.34K shares derived: sum of 3 quarters · filed 2014-12-12 | 78.09K shares derived: sum of 4 quarters · filed 2014-12-12 | ||||
| 2013-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | 23.85K shares derived: sum of 2 quarters · filed 2014-12-12 | 34.60K shares derived: sum of 3 quarters · filed 2014-12-12 | 73.98K shares 10-K/A · filed 2014-12-12 | ||||
| 2013-09-30 | 23.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | 34.60K shares derived: sum of 2 quarters · filed 2013-11-08 | 73.98K shares 10-Q · filed 2013-11-08 | 108.63K shares derived: sum of 4 quarters · filed 2014-12-12 | ||||
| 2013-06-30 | 10.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | 50.13K shares 10-Q · filed 2013-08-01 | 84.78K shares derived: sum of 3 quarters · filed 2014-12-12 | 102.22K shares derived: sum of 4 quarters · filed 2014-12-12 | ||||
| 2013-03-31 | 39.38K shares 10-Q · filed 2013-05-08 | 74.03K shares derived: sum of 2 quarters · filed 2014-12-12 | 91.47K shares derived: sum of 3 quarters · filed 2014-12-12 | |||||
| 2012-12-31 | 34.65K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | 52.10K shares derived: sum of 2 quarters · filed 2014-12-12 | 118.03K shares 10-K/A · filed 2014-12-12 | |||||
| 2012-09-30 | 17.45K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | 83.37K shares 10-Q · filed 2012-11-14 | ||||||
| 2012-06-30 | 65.93K shares 10-Q/A · filed 2012-11-14 | |||||||
| 2011-12-31 | 50.78K shares 10-K/A · filed 2014-12-12 | |||||||
| 2010-12-31 | 130.18K shares 10-K · filed 2013-03-14 |